Nvidia Stock: 13% Plunge Raises Investor Cautionby Lilu Anderson 26.06.2024"Nvidia's stock plunges 13% due to profit-taking after a 700% surge; despite the dip, strong performance and new tech suggest ...
Monkeys, Models, Markets: Debunking Behavioral Finance Mythsby Mark Eisenberg 26.06.2024Explore how AI might change financial trading, from battling human biases to understanding behavioral finance, in our insightful article.
DOGE Price Prediction for June 26, 2024: What’s Next?by Terry Bingman 26.06.2024Learn expert insights into Dogecoin's price trends, volume, and market sentiment to predict DOGE's potential movement in the next 72 ...
BTC Price Prediction: What to Expect on June 26, 2024by Terry Bingman 26.06.2024Accurately predicting Bitcoin's price in the next 72 hours using past data analysis, technical indicators, and market sentiment for traders.
ETH Price Prediction: Will Ethereum Soar on 26.06.2024?by Terry Bingman 26.06.2024Discover Ethereum's potential price movements over the next 72 hours with detailed analysis of support, resistance levels, and market sentiment.
German Government Shifts 400 BTC to Coinbase and Krakenby John Darbie 25.06.2024German police move 400 BTC to Coinbase and Kraken amid market dip, sparking sell-off speculations. Wallet now holds 46,395 BTC ...
FBI Issues Warning on Fake Law Firms Exploiting Crypto Victimsby John Darbie 25.06.2024FBI warns of fake law firms scamming crypto victims, posing as recovery agents. Protect personal info and verify claims to ...
US Clarifies Antitrust Enforcement in Meatpacking Industryby Mark Eisenberg 25.06.2024USDA's new rule plans to help farmers challenge unfair meatpacking practices, aiming for fairer markets and increased competition in the ...
AI Hardware Market Poised to Surpass USD 84.9 Billion by 2031by Lilu Anderson 25.06.2024Global AI hardware market to grow from $13.3B in 2022 to $84.9B by 2031, driven by advances in tech and ...
Alnylam’s HELIOS-B Review: Conflicting Insights Analyzedby Lilu Anderson 25.06.2024Explore conflicting analyst opinions on Alnylam's HELIOS-B data, contrasting efficacy views for vutrisiran in addressing ATTR-CM treatments.